Core Scientific’s (CORZ) Buy Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Core Scientific (NASDAQ:CORZ) in a report published on Tuesday morning,Benzinga reports. HC Wainwright currently has a $25.00 target price on the stock. HC Wainwright also issued estimates for Core Scientific’s Q1 2026 earnings at $0.07 EPS, Q2 2026 earnings at $0.09 EPS, Q3 2026 earnings at $0.09 EPS, Q4 2026 earnings at $0.09 EPS and FY2026 earnings at $0.33 EPS.

Several other research analysts have also issued reports on the stock. Citigroup raised shares of Core Scientific from a “market perform” rating to an “outperform” rating in a research note on Thursday, December 18th. Citizens Jmp upgraded shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price objective on the stock in a report on Thursday, December 18th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Core Scientific in a research report on Wednesday, January 21st. Keefe, Bruyette & Woods upped their price target on Core Scientific from $19.00 to $25.00 and gave the stock a “moderate buy” rating in a research note on Tuesday, January 27th. Finally, BTIG Research raised Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price objective for the company in a research note on Tuesday, January 6th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $24.84.

Core Scientific Stock Performance

CORZ stock opened at $16.00 on Tuesday. The company has a market capitalization of $5.05 billion, a P/E ratio of 13.68 and a beta of 6.87. The company has a fifty day moving average price of $17.28 and a 200-day moving average price of $16.95. Core Scientific has a 52-week low of $6.20 and a 52-week high of $23.63.

Core Scientific (NASDAQ:CORZ) last announced its earnings results on Monday, March 2nd. The company reported $0.42 EPS for the quarter, beating the consensus estimate of ($0.27) by $0.69. The company had revenue of $79.76 million during the quarter, compared to the consensus estimate of $118.45 million. The business’s revenue was down 16.0% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.69) earnings per share. As a group, sell-side analysts forecast that Core Scientific will post 0.52 earnings per share for the current fiscal year.

Institutional Trading of Core Scientific

Several hedge funds have recently made changes to their positions in CORZ. Nisa Investment Advisors LLC boosted its position in Core Scientific by 192.3% during the second quarter. Nisa Investment Advisors LLC now owns 4,662 shares of the company’s stock worth $80,000 after purchasing an additional 3,067 shares during the period. Harvest Portfolios Group Inc. boosted its holdings in Core Scientific by 81.9% in the 2nd quarter. Harvest Portfolios Group Inc. now owns 134,895 shares of the company’s stock worth $2,303,000 after buying an additional 60,746 shares during the period. ORG Wealth Partners LLC grew its stake in Core Scientific by 1.8% in the 3rd quarter. ORG Wealth Partners LLC now owns 7,290,481 shares of the company’s stock valued at $130,791,000 after buying an additional 128,284 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in Core Scientific by 39.9% during the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 452,806 shares of the company’s stock valued at $8,123,000 after acquiring an additional 129,133 shares during the period. Finally, Prudential Financial Inc. raised its holdings in Core Scientific by 1,326.9% during the 2nd quarter. Prudential Financial Inc. now owns 199,630 shares of the company’s stock valued at $3,408,000 after acquiring an additional 185,640 shares during the period.

Core Scientific News Summary

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: HC Wainwright reiterated a Buy, materially raised FY2026 EPS (from $0.16 to $0.33) and published quarterly EPS estimates with a $25 price target — a clear analyst endorsement that supports the rally. HC Wainwright Reiterates Buy
• Positive Sentiment: Canaccord raised its price target from $17 to $20 and maintained a Buy rating, adding upward price-target momentum. Canaccord PT Raised to $20
• Positive Sentiment: MarketBeat and other coverage argue the company’s pivot to AI colocation (including a reported $10B+ backlog and rapid colocation growth) creates multi-year upside and institutional buying support, which can drive investor interest despite short-term churn. Core Scientific’s $10 Billion AI Shift
• Neutral Sentiment: CoreWeave contract progress: reports note the CoreWeave deal is ahead of schedule and colocation revenue is ramping, a structural positive; however, this is balanced by transitional revenue mix changes. CoreWeave Deal Ahead of Schedule
• Neutral Sentiment: Short-interest data in recent filings shows anomalous “0 shares” readings (likely a reporting glitch); current days-to-cover appears negligible — this item is noisy and should not be overinterpreted.
• Negative Sentiment: Q4 2025 results showed revenue weakness (reported as a 38% YoY decline in one summary) and a sharp earnings swing tied to the pivot, which earlier drove a significant intraday drop. Investors remain sensitive to near-term top-line contraction and negative adjusted EBITDA while expansion investments continue. Core Scientific 2025 earnings: revenue falls 38% YoY
• Negative Sentiment: At least one firm (Ladenburg Thalmann) lowered expectations, reflecting some analyst caution on near-term execution risks and balance-sheet concerns tied to the transition. Ladenburg Lowers Expectations

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.